Is Windlas biotech a good company?
1. Is Windlas Biotech Ltd a good quality company? Past 10 year’s financial track record analysis by Moneyworks4me indicates that Windlas Biotech Ltd is a average quality company.
Who owns Windlas biotech?
Ashok Kumar Windlass, Hitesh Windlass, Manoj Kumar Windlass and the Promoter Trust are the promoters of the company, having a total shareholding of 70.20 percent of the pre-offer paid-up equity share capital. Vivek Dhariwal is the Chairman and Non-Executive Independent Director of the company.
What is Windlas biotechnology?
Windlas Biotech Limited offers long-term Contract Manufacturing services right from strategic partnership in development and validations to manufacturing of pharmaceutical ingredients.
Is Windlas biotech profitable?
Over FY19-21, Windlas Biotech’s revenue and operating profit has grown at a CAGR of 18-19%. Contract manufacturing offers significant opportunities for growth too.
Can I hold Windlas biotech?
Most experts Moneycontrol spoke to advise holding Windlas Biotech shares for the long term while short-term investors can book profits. As for Exxaro, the advise booking profits. Prashanth Tapse, VP Research at Mehta Equities said that investors who were allotted shares can hold their stake for the long term.
Is Windlas biotech debt free?
At present, the company has around Rs 30 crore of debt. After the IPO, the debt is expected to be down by Rs 10 crore. Gupta added that the company despite debt has enough liquidity. Windlas Biotech has Rs 55 crore in banks, mutual funds and other liquid instruments.
Which IPO is best in India?
Top 10 IPO in India 2022 (By Performance)
|Company Name||Listing Date||Issue Price (Rs)|
|Adani Wilmar Limited||Feb 08, 2022||230|
|Vedant Fashions Limited||Feb 16, 2022||866|
|AGS Transact Technologies Ltd||Jan 31, 2022||175|
Is Nykaa public?
Nykaa’s IPO closes for public subscription on November 1. The initial public offering (IPO) of FSN E-Commerce Ventures Limited, the parent company of Nykaa, closes for subscription today. The public offering saw solid response on the first two days of bidding and is going strong on the third day as well.
Who is windlas Biotech Limited?
WINDLAS BIOTECH LIMITED Our Company was incorporated as ‘Windlas Biotech Limited’ on February 19, 2001 at New Delhi as a public limited company under the Companies Act, 1956 and was granted a certificate of incorporation by the Assistant Registrar of Companies, National Capital Territory of Delhi and Haryana, at New Delhi (“RoC Delhi”).
How to contact Windl biotech Gurgaon?
Windlas Biotech Private Limited 705-706, Vatika Professional Point, Sector-66 Golf Course Extension Road Gurgaon – 122 001 Haryana, India Tel.: +91 124 2821030. Contact. We shall be happy to receive your enquiries and revert: +91 124 2821030. [email protected]
What happened to windlas healthcare?
Divestment of Windlas Healthcare: On October 29, 2018, Windlas Healthcare issued 24,077,950 equity shares at face value ₹ 10 each along with premium of ₹ 54.60 (total value, including premium, amounting to ₹ 64.60) to Cadila for a consideration of ₹ 1,555.50 million.
Does Cadila own windlas Healthcare Private Limited?
3. In Fiscal 2019, Cadila Healthcare Limited acquired 51.00% of the total equity share capital of Windlas Healthcare Private Limited.